Researchers reported that profiling the bone marrow “metabolome" at the time of pediatric acute lymphoblastic leukemia diagnosis enabled them to identify patients who were most likely to respond poorly to treatment.
To better understand the specific roles different immune cell types play, a multi-institutional team profiled the immune cell composition of multiple murine models and clinical datasets of triple negative breast cancers.
Researchers have been studying Hurricane Harvey's effect on public health and the emergency response by healthcare providers during a major disaster. On Thursday, Aug. 22, they will share what they have learned at a symposium.
The Mesothelioma Treatment Center at the Baylor College of Medicine Lung Institute is looking for malignant pleural mesothelioma patients to try a new treatment that combines immunotherapy with a new drug that accelerates cell death.
A cancer immunotherapy research group at Baylor College of Medicine has secured Investigational New Drug regulatory clearance through the FDA to perform phase I clinical studies in newly-diagnosed adult patients with glioblastoma.
Gliogene, a study that aims to identify hereditary links of glioma, a rare and deadly form of brain cancer, has begun recruiting families affected by the disease in order to identify genes that contribute to its onset and inform susceptibility.
In a new study, ethics scholar Dr. Stephanie Morain explores a trend of oncology trial recruitment via mobile apps, and what these app companies and consumers need to consider in terms of privacy and data protection